SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Astronics Corporation (ATROB) trades at a trailing P/E of 92.6, forward P/E of 28.4. Trailing earnings yield is 1.08%, forward earnings yield 3.52%. PEG 0.13 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 92.6).
- Forward P/E 28.4 (down from trailing 92.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.13 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 1.08% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.52% as earnings recover.
Overall SharesGrow Score: 45/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ATROB
Valuation Multiples
P/E (TTM)92.6
Forward P/E28.4
PEG Ratio0.13
Forward PEG0.13
P/B Ratio0.00
P/S Ratio3.35
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.81
Forward EPS (Est.)$2.64
Book Value / Share$0.00
Revenue / Share$22.40
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1.08%
Forward Earnings Yield3.52%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.40 |
$633.12M |
$48.42M |
7.6% |
| 2017 |
$0.58 |
$624.46M |
$19.68M |
3.2% |
| 2018 |
$1.41 |
$803.26M |
$46.8M |
5.8% |
| 2019 |
$1.60 |
$772.7M |
$52.02M |
6.7% |
| 2020 |
$-3.76 |
$502.59M |
$-115.78M |
-23% |
| 2021 |
$-0.82 |
$444.91M |
$-25.58M |
-5.7% |
| 2022 |
$-1.11 |
$534.89M |
$-35.75M |
-6.7% |
| 2023 |
$-0.80 |
$689.21M |
$-26.42M |
-3.8% |
| 2024 |
$-0.46 |
$795.43M |
$-16.22M |
-2% |
| 2025 |
$0.81 |
$862.13M |
$29.36M |
3.4% |
